Pond Technologies Sees Success In Production Of Proteins From Algae Under Partnership

Pond technologies (CSE: POND) continues to see success within its biotech division. The company this morning indicated it ahs seen successful results from the production of recombinant proteins, via a project undertaken last August with a major Canadian oilsands producer and Fortune 500 company.

Under the project, the company is producing complex proteins for the use in diagnostics and therapeutics. The proteins, referred to as recombinant proteins, are being grown via algae. Deliveries of the algae to the consortium for testing has reportedly been underway since the beginning of 2022, with weekly deliveries of such proteins occurring.

Initial scale up of the program has now been completed, which includes growth protocols as well as bioreactor designs. With the current trials under way, the successful results to date have now been published in the scientific journal Nature Scientific Reports, the 6th most cited journal globally.

“This peer reviewed journal article supports our view that algae can be a low-cost micro-factory for the production of recombinant proteins, with applications in medical diagnostics, antibody therapeutics, and vaccine manufacture. We expect to complete this project and continue to grow revenues from our biotech division in 2023,” said Grant Smith, CEO.

With the project to consist of compensation of up to $1.0 million for the Pond, the company to date has reportedly collected $230,000 in revenue from the program. The company also expects to receive a further $850,000 for its efforts via the form of milestone payments, with a commercial supply contract potentially being entered into by years end.

The development follows the company last week indicating that it expects an animal feed pilot plant to be online by the years end, under a partnership with a subsidiary of Associated British Foods. The partnership aims to produce animal feed from CO2 emissions via the use of algae.

Pond Technologies last traded at $0.19 on the CSE.


FULL DISCLOSURE: Pond Technologies is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pond Technologies on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Pond Technologies Enters Research Collaboration To Examine Methane Reducing Algae Feed Solutions

Pond Technologies (CSE: POND) has entered into a fresh research agreement. The arrangement, entered into...

Thursday, April 28, 2022, 08:28:10 AM

Pond Technologies To Raise $1.0 Million At Premium To Market

Pond Technologies (TSXV: POND) this morning indicated it is looking to complete a small financing...

Tuesday, September 6, 2022, 02:47:00 PM

Pond Tech: Converting CO2 Into Algae – The Daily Dive

Joining us for the first time on the Daily Dive today is Grant Smith, CEO...

Thursday, March 31, 2022, 01:30:00 PM

Pond Technologies Receives $350,000 Milestone Payment Under Contract With Fortune 500 Partner

Milestones continue to be met by Pond Technologies (TSXV: POND) in connection with a contract...

Thursday, October 20, 2022, 12:45:19 PM

Pond Technologies Expects Animal Feed Pilot Plant To Be Online By Year End

Pond Technologies (TSXV: POND) appears to be getting underway with its partnership related to the...

Thursday, May 5, 2022, 09:02:51 AM